These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin? Guay DR Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325 [TBL] [Abstract][Full Text] [Related]
5. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Schifano F; D'Offizi S; Piccione M; Corazza O; Deluca P; Davey Z; Di Melchiorre G; Di Furia L; Farré M; Flesland L; Mannonen M; Majava A; Pagani S; Peltoniemi T; Siemann H; Skutle A; Torrens M; Pezzolesi C; van der Kreeft P; Scherbaum N Psychother Psychosom; 2011; 80(2):118-22. PubMed ID: 21212719 [No Abstract] [Full Text] [Related]
6. A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system. Schwan S; Sundström A; Stjernberg E; Hallberg E; Hallberg P Eur J Clin Pharmacol; 2010 Sep; 66(9):947-53. PubMed ID: 20563568 [TBL] [Abstract][Full Text] [Related]
7. Potential for pregabalin abuse or diversion after past drug-seeking behavior. Filipetto FA; Zipp CP; Coren JS J Am Osteopath Assoc; 2010 Oct; 110(10):605-7. PubMed ID: 21068226 [TBL] [Abstract][Full Text] [Related]
8. [Pregabalin should be moved to the prescription group B]. Westin AA; Bramness JG; Chalabianloo F; Rygnestad T; Slørdal L Tidsskr Nor Laegeforen; 2013 Mar; 133(6):615-6. PubMed ID: 23552152 [No Abstract] [Full Text] [Related]
9. Pregabalin abuse after past substance-seeking behavior. Papazisis G; Garyfallos G; Sardeli C; Kouvelas D Int J Clin Pharmacol Ther; 2013 May; 51(5):441-2. PubMed ID: 23547854 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. Bockbrader HN; Burger P; Knapp L; Corrigan BW Epilepsia; 2011 Feb; 52(2):248-57. PubMed ID: 21269291 [TBL] [Abstract][Full Text] [Related]
15. Pregabalin's abuse potential: a mini review focusing on the pharmacological profile. Papazisis G; Tzachanis D Int J Clin Pharmacol Ther; 2014 Aug; 52(8):709-16. PubMed ID: 24849194 [TBL] [Abstract][Full Text] [Related]
16. Pregabalin: a new neuromodulator with broad therapeutic indications. Shneker BF; McAuley JW Ann Pharmacother; 2005 Dec; 39(12):2029-37. PubMed ID: 16288079 [TBL] [Abstract][Full Text] [Related]
17. Rash associated with pregabalin use. Smith TL; Baldwin A; Cunningham LL; Cook AM Ann Pharmacother; 2008 Dec; 42(12):1899-902. PubMed ID: 19001532 [TBL] [Abstract][Full Text] [Related]
18. Pregabalin: new drug. Very similar to gabapentin. Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976 [TBL] [Abstract][Full Text] [Related]
19. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683 [TBL] [Abstract][Full Text] [Related]